Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IN8bio, Inc. - Common Stock (NQ:INAB)

2.132 -0.048 (-2.19%)
Streaming Delayed Price Updated: 11:07 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about IN8bio, Inc. - Common Stock

William Ho, CEO of In8bio Inc. (NASDAQ: INAB), to Present at NobleCon20
Via Investor Brand Network
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
From IN8bio, Inc
Via GlobeNewswire
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
From IN8bio, Inc
Via GlobeNewswire
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
From IN8bio, Inc
Via GlobeNewswire
IN8bio Inc. (NASDAQ: INAB) Near the Top of Equities by Percentage Gain on 4/24
Via Investor Brand Network
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
From IN8bio, Inc
Via GlobeNewswire
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
From IN8bio, Inc
Via GlobeNewswire
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
From IN8bio, Inc
Via GlobeNewswire
IN8bio to Present at Upcoming Investor Conferences
From IN8bio, Inc.
Via Business Wire
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END 
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.